Tiltan Pharma's Unattributed Round

Tiltan Pharma raised a round of funding on February 05, 2014.

Tiltan Pharma is a biotechnology company dedicated to the development and commercialization of its proprietary anti-angiogenic platform for the treatment of cancer and other indications. The Company i…

Articles about Tiltan Pharma's Unattributed Round: